Michael J. Rieder, M.D., Ph.D.

Pediatrics, Pharmacology University of Western Ontario, London, Ontario, Canada 
Immunopharmacology, Immune reactions
"Michael Rieder"
Mean distance: 23.43 (cluster 40)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rieder M. (2020) Authorizing medical cannabis for children Paediatrics and Child Health. 25
Knoppert D, Rieder MJ. (2020) Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List. The Journal of Pediatric Pharmacology and Therapeutics : Jppt. 25: 173-174
Hummel BA, Rieder M. (2019) Consider If You Will: Proton Pump Inhibitors in Children, Infections, and Precision Medicine Pediatrics. 144
Rieder M. (2019) Pharmacy and pediatric drug therapy: The key to safe and effective treatment for children. American Journal of Health-System Pharmacy. 76: 1452-1453
Kirpalani A, Rieder M. (2019) Is NSAID use in children associated with the risk of renal injury Paediatrics and Child Health. 24: 119-121
Elzagallaai A, Gill H, Rieder M. (2019) O03 Allergy to penicillins in a pediatric population: reported vs true Archives of Disease in Childhood. 104
Poonai N, Faught L, Elzagallaai B, et al. (2019) 67 Oral morphine pharmacokinetics and characterization of pharmacogenomic phenotypes in children Paediatrics & Child Health. 24: e26-e27
Rieder M. (2018) Adverse Drug Reactions Across the Age Continuum: Epidemiology, Diagnostic Challenges, Prevention, and Treatments The Journal of Clinical Pharmacology. 58: 36
Barker CIS, Standing JF, Kelly LE, et al. (2018) Pharmacokinetic studies in children: recommendations for practice and research. Archives of Disease in Childhood
Canton KR, Hendrikx S, Joubert G, et al. (2018) Intranasal Ketamine for Procedural Sedation and Analgesia in Children: A Systematic Review Pediatrics. 141: 350-350
See more...